US6183414B1 - Technique for restoring plasticity to tissues of a male or female organ - Google Patents

Technique for restoring plasticity to tissues of a male or female organ Download PDF

Info

Publication number
US6183414B1
US6183414B1 US09/299,284 US29928499A US6183414B1 US 6183414 B1 US6183414 B1 US 6183414B1 US 29928499 A US29928499 A US 29928499A US 6183414 B1 US6183414 B1 US 6183414B1
Authority
US
United States
Prior art keywords
organ
technique
tissues
plasticity
erectile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US09/299,284
Inventor
Michael S. Wysor
Wanda D. Wysor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/299,284 priority Critical patent/US6183414B1/en
Assigned to EBERT, MICHAEL reassignment EBERT, MICHAEL ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WYSOR, MICHAEL S., WYSOR, WANDA D.
Application granted granted Critical
Publication of US6183414B1 publication Critical patent/US6183414B1/en
Priority to US10/174,482 priority patent/US20030023140A1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14553Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41Devices for promoting penis erection
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N21/3151Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using two sources of radiation of different wavelengths
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/4795Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • G01N21/49Scattering, i.e. diffuse reflection within a body or fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0233Special features of optical sensors or probes classified in A61B5/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/02Details of sensors specially adapted for in-vivo measurements
    • A61B2562/0233Special features of optical sensors or probes classified in A61B5/00
    • A61B2562/0242Special features of optical sensors or probes classified in A61B5/00 for varying or adjusting the optical path length in the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2562/00Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
    • A61B2562/04Arrangements of multiple sensors of the same type
    • A61B2562/043Arrangements of multiple sensors of the same type in a linear array
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/41Devices for promoting penis erection
    • A61F2005/411Penile supports
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01JMEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
    • G01J9/00Measuring optical phase difference; Determining degree of coherence; Measuring optical wavelength
    • G01J9/04Measuring optical phase difference; Determining degree of coherence; Measuring optical wavelength by beating two waves of a same source but of different frequency and measuring the phase shift of the lower frequency obtained
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N2021/1789Time resolved
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N2021/1789Time resolved
    • G01N2021/1791Time resolved stroboscopic; pulse gated; time range gated
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/314Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths
    • G01N2021/3181Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry with comparison of measurements at specific and non-specific wavelengths using LEDs
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/47Scattering, i.e. diffuse reflection
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/061Sources
    • G01N2201/06113Coherent sources; lasers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00Features of devices classified in G01N21/00
    • G01N2201/06Illumination; Optics
    • G01N2201/069Supply of sources
    • G01N2201/0696Pulsed

Definitions

  • This invention relates generally to the treatment of male impotence, and more particularly, to a technique for this purpose which is applied to a male organ whose tissues lack sufficient plasticity to achieve and maintain an erection, the technique acting to restore the plasticity of these tissues and thereby overcome impotence.
  • Male impotence is an abnormal condition in which an individual is unable to achieve and maintain an adequate penile erection for coitus. Because male impotence is now widespread, it has attracted considerable medical and scientific interest directed toward finding an effective treatment therefor.
  • male impotence can also be an adverse side effect of some prescription drugs or result from substance abuse.
  • these do not account for a high percentage of male impotence cases.
  • the loss of plasticity is not an overnight phenomenon, but is a gradual process which is insidious. As an individual experiences a gradual loss of plasticity, he then tend to reduce his sexual activity, for he finds it increasingly difficult to attain an erection. The resultant inactivity of the male organ gives rise to a further loss of plasticity until a point is reached where the individual becomes effectively impotent and is unable to function sexually despite the fact that he is otherwise healthy and in good physical condition.
  • the degree to which the tissues of a male organ possess or lack plasticity is easily determined. With normal plasticity, the organ feels rubbery and elastic, whereas when the organ loses plasticity, it becomes softer and mushy, sponge-like or flabby.
  • the male organ is composed of three columns of erectile tissue, two dorsolateral (corpa cavernosa) and one medial (corpus spongiosum) which contain the urethra and expands at the end to form the glans penis.
  • the tissues support blood vessels that perform complex hemodynamic processes. For an erection to occur and be maintained, the arterioles, the veins as well as valves in the veins, must work in conjunction with changes taking place in the penile tissues. A loss of plasticity adversely affects the dynamics of flow in the arterioles and veins and impairs the ability of the valves in the venous system to operate properly.
  • the caverns of the corpus cavernosum fill with blood and dilate. This action stretches the smooth muscles lining the walls of these caverns and the connective tissue disposed therebetween. The two erectile cylinders then increase dramatically in size. When the erection thereafter subsides, the elastic recoil of the walls return the caverns to their normal size.
  • the ability of a male organ to achieve and maintain an erectile state therefore depends on the plasticity of its tissues, this plasticity determining the fitness of the sexual organ for its intended purpose.
  • vasodilators such as prostaglandins (Alprostadil). These drugs act to dilate the cavernosal arteries, resulting in an increased arterial inflow velocity. But should the tissues of the penis lack plasticity, the penis may not achieve and maintain an erectile state.
  • the Lederer U.S. Pat. No. 1,225,341 places an impotent male organ in a vacuum chamber which acts to draw blood into the penis to induce vacuum engorgement.
  • the penis is then erect, this erection being secured by means of an elastic cincture band which acts as a tourniquet to prevent the blood from leaving the penis.
  • VED vacuum erection device
  • the main object of this invention is to provide a technique for overcoming male impotence when due to a loss of plasticity of the tissues of the male organ, the technique acting to restore plasticity to the tissues.
  • an object of the invention is to provide an electrically-powered apparatus of the above type in which a vacuum device acts to create a negative pressure that draws blood into the male organ engaged by the device, which device in the course of each operating cycle compels the organ to change from a flaccid to an erectile state and then revert to a flaccid state.
  • Yet another object of the invention is to provide a technique to overcome male impotence which when properly practiced has no adverse side effects.
  • these objects are attained by a technique for overcoming male impotence when this condition is due to an insufficient plasticity of the tissues of the male organ to achieve and maintain an erectile state.
  • the male organ to be treated is engaged by an erectile enhancement device which in the course of each operating cycle for a predetermined number of times compels the organ to change from a flaccid to an erectile state and then revert to the flaccid state.
  • the device is programmed to repeat this operating cycle during an exercise session that subjects the male organ to a workout that enhances the plasticity of the tissues. Impotence is overcome when the individual completes a series of such exercise sessions.
  • FIG. 1 is a block diagram of an apparatus for carrying out a technique in accordance with the invention to overcome male impotence
  • FIG. 2 graphically illustrates one operating cycle of the apparatus
  • FIG. 3 shows the operating pattern of an exercise session for effecting a workout of the tissues of the male organ being treated
  • FIG. 4 shows another pattern of operating cycles.
  • a technique in accordance with the invention is applicable to a male organ that is more or less impotent because the tissues thereof have lost much of their. normal plasticity or tone whereby the organ is then unable to achieve and maintain the erectile state necessary for coitus.
  • tone is appropriate to describe the condition of the tissues.
  • tone refers to the normal state of elastic tension or partial contraction in resting muscles.
  • the term tone is more generally defined in Webster's Third New International Dictionary as “healthy or normal elasticity.”
  • a vacuum erection device is provided, the device being composed of a vacuum chamber 10 and a self-contained, battery-operated pump assembly 11 coupled to one end of the chamber.
  • Chamber 10 is preferably a cylinder of transparent plastic material, such as a polyacrylic, so that one can observe the male organ P received in the vacuum chamber.
  • the vacuum chamber and pump assembly may be of the type disclosed in the Osborne et al. U.S. Pat. No. 5,421,808 in which the vacuum chamber is tapered toward the penis-introducing end to facilitate full engorgement of the glans penis.
  • a negative pressure indicator 12 to permit a user to monitor the degree of negative pressure applied to penis P.
  • an electrical programmer 13 associated with assembly 11 is an electrical programmer 13 which is arranged to establish the timing of an operating cycle and of an exercise session appropriate to the individual being treated.
  • Exercise of the tissues of the organ is effected by a timed program in which during each operating cycle of the apparatus, as shown in FIG. 2, a male organ, initially in a flaccid state F at the start of the cycle, is subjected in the vacuum chamber to a negative pressure which draws blood into the organ and engorges the organ so that it assumes an erectile state E.
  • the vacuum is held to maintain the organ in an erectile state E for a brief interval, such as thirty seconds to a minute, after which the vacuum is released to cause the penis to revert to its flaccid state F.
  • This operating cycle acts to replicate the dynamics of achieving and losing an erection in the course of which the volume of the corpus cavernos is expanded and then contracted to simulate the natural process.
  • the tissues of the male organ in the course of this operating cycle are stretched to attain the erectile state and then contract to re-assume the flaccid state.
  • the clinical pattern of recovery involves a gradual, but steady increase in erectile function. We have treated over 400 patients with this technique and none have failed to show a positive response. While the VED exercise technique acts to restore potency, once it is restored and the subject can function sexually this does preclude further treatment. As with athletes, the way to maintain muscle tone is to continue to exercise, just as a concert pianist must practice daily to maintain his digital dexterity. And while a recovered subject need not exercise his penile tissues five days a week, as he did when striving to recover his potency, he should continue to exercise at least once a week.
  • the negative pressure is such as to cause the male organ P to go from a flaccid to a fully erectile state and then back to a flaccid state; this being repeated with each new operating cycle. But it may be desirable to progressively increase the degree of exertion so as not to overtax the tissues being exercised.
  • the first operating cycle C 1 may be arranged to cause the male organ to change from a flaccid state and to a sub-erectile state. This being about one half the level of the normal erectile state; the second cycle C 2 raises the level somewhat higher, and the third cycle C 3 raises it still higher, but below the full erectile state which is not attained until cycle C 4 .
  • Programmer 13 is provided with a keyboard 14 so that the operator of the apparatus can enter into the device timing parameters appropriate to the subject being treated.
  • the technique is also beneficial in the treatment of female impotence when due to the loss of plasticity of the tissues of the clitoris whose tissues are similar to those of the male organ. But in order to exercise the tissues of the clitoris, the vacuum chamber for this purpose must be adapted to accommodate the clitoris such that when a negative pressure is produced, this draws blood into the clitoris which then becomes engorged.

Abstract

A technique for overcoming male impotence when this condition is due to a loss of plasticity in the tissues of the male organ, making it incapable of achieving and maintaining an erectile state. To practice this technique, the male organ to be treated is engaged by an erectile enhancement device which in the course of each operating cycle compels the organ to change from a flaccid to an erectile state and then revert to the flaccid state. The device is programmed to repeat this operating cycle a predetermined number of times during an exercise session that subjects the male organ to a workout that enhances the plasticity of the tissues. Impotence is overcome when the individual completes a series of such exercise sessions.

Description

BACKGROUND OF INVENTION
1. Field of Invention
This invention relates generally to the treatment of male impotence, and more particularly, to a technique for this purpose which is applied to a male organ whose tissues lack sufficient plasticity to achieve and maintain an erection, the technique acting to restore the plasticity of these tissues and thereby overcome impotence.
2. Status of Prior Art
Male impotence is an abnormal condition in which an individual is unable to achieve and maintain an adequate penile erection for coitus. Because male impotence is now widespread, it has attracted considerable medical and scientific interest directed toward finding an effective treatment therefor.
While male impotence is usually imputed to the aging process, it is by no means a condition confined to older men. Thus it is not unusual to find an individual of no more than 20 years of age exhibiting the early symptoms of male impotence.
Male impotence has often been attributed to psychological factors, such as stress, depression, financial worries and a failing marriage. But in our clinical experience with patients who suffer from male impotence, psychological factors account for only a small percentage of male impotence cases.
Various diseases, such as diabetes and multiple sclerosis may give rise to male impotence, and male impotence can also be an adverse side effect of some prescription drugs or result from substance abuse. However, in our clinical studies, these do not account for a high percentage of male impotence cases.
In these studies we have found that the most significant factor accounting for male impotence is the impaired physical fitness of the male organ, per se, separate and apart from all other considerations. Thus a subject who is free of disease and of psychological disorders, and who seemingly is in superb physical condition, may nevertheless be unable to perform sexually.
We have found that the physical fitness of a male organ depends on the plasticity of its tissues. Our studies show that the central core lesion in male impotence is a loss of plasticity so that the tissues of the organ are unable to stretch and expand to permit the organ to change from an initially flaccid state to an erectile state. It is only when the tissues of the male organ possess a normal degree of plasticity that the organ is then capable of achieving and maintaining the erectile state necessary for coitus and ejaculation. A loss of plasticity of the penile tissues of the corpus cavernosum renders the male organ incapable of expanding and contracting.
The loss of plasticity is not an overnight phenomenon, but is a gradual process which is insidious. As an individual experiences a gradual loss of plasticity, he then tend to reduce his sexual activity, for he finds it increasingly difficult to attain an erection. The resultant inactivity of the male organ gives rise to a further loss of plasticity until a point is reached where the individual becomes effectively impotent and is unable to function sexually despite the fact that he is otherwise healthy and in good physical condition.
The degree to which the tissues of a male organ possess or lack plasticity is easily determined. With normal plasticity, the organ feels rubbery and elastic, whereas when the organ loses plasticity, it becomes softer and mushy, sponge-like or flabby.
The male organ is composed of three columns of erectile tissue, two dorsolateral (corpa cavernosa) and one medial (corpus spongiosum) which contain the urethra and expands at the end to form the glans penis. The tissues support blood vessels that perform complex hemodynamic processes. For an erection to occur and be maintained, the arterioles, the veins as well as valves in the veins, must work in conjunction with changes taking place in the penile tissues. A loss of plasticity adversely affects the dynamics of flow in the arterioles and veins and impairs the ability of the valves in the venous system to operate properly.
During erection, the caverns of the corpus cavernosum fill with blood and dilate. This action stretches the smooth muscles lining the walls of these caverns and the connective tissue disposed therebetween. The two erectile cylinders then increase dramatically in size. When the erection thereafter subsides, the elastic recoil of the walls return the caverns to their normal size.
The ability of a male organ to achieve and maintain an erectile state therefore depends on the plasticity of its tissues, this plasticity determining the fitness of the sexual organ for its intended purpose.
As the ability to maintain an erection diminishes, there is a corresponding decline in the plasticity of the tissues. Both processes feed on each other in a spiraling descent leading to a condition of total impotence.
When male impotence is due to the loss of plasticity of the tissues of the penis, this condition cannot be overcome by the use of vasodilators, such as prostaglandins (Alprostadil). These drugs act to dilate the cavernosal arteries, resulting in an increased arterial inflow velocity. But should the tissues of the penis lack plasticity, the penis may not achieve and maintain an erectile state.
Heretofore, the treatment of male impotence was not calculated to overcome impotence, but to simulate potency by artificial means causing an impotent male organ to assume an erectile state.
To this end, the Lederer U.S. Pat. No. 1,225,341 places an impotent male organ in a vacuum chamber which acts to draw blood into the penis to induce vacuum engorgement. When the penis is in an engorged state it is then erect, this erection being secured by means of an elastic cincture band which acts as a tourniquet to prevent the blood from leaving the penis.
The Osborne U.S. Pat. Nos. 4,378,008, 5,083,556 and 4,856,498 disclose various types of vacuum enhancement devices in which a vacuum chamber is provided with a port into which a flaccid penis is inserted, the vacuum chamber being coupled to a manual pump.
Of greater prior art interest is the Osborne et al. U.S. Pat. No. 5,421,808. This patent discloses a self-contained battery-operated external vacuum device that includes an electric motor coupled to a reciprocating diaphragm pump. Because this vacuum device is electrically-powered, it is more easily regulated and controlled.
A vacuum erection device (VED), whether manually or electrically operated, does not cure impotence, but simply acts to simulate potency. Thus when this device by means of a negative pressure draws blood into the penis so that it is engorged, this imitates a normal erection. However to maintain this synthetic erection, the penis must be girded to prevent the blood from escaping.
While an individual who simulates an erection by means of a vacuum erection device can perform coitus, the engorged penis is effectively a dildo which is a poor substitute for a normally erect penis capable of ejaculating. Hence sexual activity made possible by a vacuum erection device in many respects falls short of natural coitus.
SUMMARY OF INVENTION
In view of the foregoing, the main object of this invention is to provide a technique for overcoming male impotence when due to a loss of plasticity of the tissues of the male organ, the technique acting to restore plasticity to the tissues.
More particularly, an object of the invention is to provide an electrically-powered apparatus of the above type in which a vacuum device acts to create a negative pressure that draws blood into the male organ engaged by the device, which device in the course of each operating cycle compels the organ to change from a flaccid to an erectile state and then revert to a flaccid state.
Yet another object of the invention is to provide a technique to overcome male impotence which when properly practiced has no adverse side effects.
Briefly stated, these objects are attained by a technique for overcoming male impotence when this condition is due to an insufficient plasticity of the tissues of the male organ to achieve and maintain an erectile state. To practice this technique, the male organ to be treated is engaged by an erectile enhancement device which in the course of each operating cycle for a predetermined number of times compels the organ to change from a flaccid to an erectile state and then revert to the flaccid state.
The device is programmed to repeat this operating cycle during an exercise session that subjects the male organ to a workout that enhances the plasticity of the tissues. Impotence is overcome when the individual completes a series of such exercise sessions.
BRIEF DESCRIPTION OF DRAWINGS
For a better understanding of the invention, as well as further features thereof, reference is made to the detailed description thereof to be read in connection with the annexed drawings wherein:
FIG. 1 is a block diagram of an apparatus for carrying out a technique in accordance with the invention to overcome male impotence;
FIG. 2 graphically illustrates one operating cycle of the apparatus;
FIG. 3 shows the operating pattern of an exercise session for effecting a workout of the tissues of the male organ being treated; and
FIG. 4 shows another pattern of operating cycles.
DESCRIPTION OF INVENTION
A technique in accordance with the invention is applicable to a male organ that is more or less impotent because the tissues thereof have lost much of their. normal plasticity or tone whereby the organ is then unable to achieve and maintain the erectile state necessary for coitus.
Inasmuch as a technique in accordance with the invention acts to exercise the tissues of a male organ as if it were a muscle, the term “tone” is appropriate to describe the condition of the tissues. In physiology, tone refers to the normal state of elastic tension or partial contraction in resting muscles. The term tone is more generally defined in Webster's Third New International Dictionary as “healthy or normal elasticity.”
When muscles are flabby and lacking in tone, they are then incapable of carrying out strenuous muscular activity. One can restore the tone of muscles by exercise. Thus a typical exerciser for the arm muscles in a helical spring with a handle attached at either end. The user pulls these handles apart to stretch the spring and then permits the spring to contract during each operating cycle of this exerciser, thereby strengthening the arm muscles. But one cannot exercise the tissues of a male organ in the manner in which one exercises arm muscles.
In an apparatus for carrying out a technique in accordance with the invention as shown in FIG. 1, a vacuum erection device is provided, the device being composed of a vacuum chamber 10 and a self-contained, battery-operated pump assembly 11 coupled to one end of the chamber. Chamber 10 is preferably a cylinder of transparent plastic material, such as a polyacrylic, so that one can observe the male organ P received in the vacuum chamber.
In practice, the vacuum chamber and pump assembly may be of the type disclosed in the Osborne et al. U.S. Pat. No. 5,421,808 in which the vacuum chamber is tapered toward the penis-introducing end to facilitate full engorgement of the glans penis.
Coupled to assembly 11 is a negative pressure indicator 12 to permit a user to monitor the degree of negative pressure applied to penis P. And associated with assembly 11 is an electrical programmer 13 which is arranged to establish the timing of an operating cycle and of an exercise session appropriate to the individual being treated.
Exercise of the tissues of the organ is effected by a timed program in which during each operating cycle of the apparatus, as shown in FIG. 2, a male organ, initially in a flaccid state F at the start of the cycle, is subjected in the vacuum chamber to a negative pressure which draws blood into the organ and engorges the organ so that it assumes an erectile state E. In the course of an operating cycle, the vacuum is held to maintain the organ in an erectile state E for a brief interval, such as thirty seconds to a minute, after which the vacuum is released to cause the penis to revert to its flaccid state F.
This operating cycle acts to replicate the dynamics of achieving and losing an erection in the course of which the volume of the corpus cavernos is expanded and then contracted to simulate the natural process. The tissues of the male organ in the course of this operating cycle are stretched to attain the erectile state and then contract to re-assume the flaccid state.
In order to give the impotent male organ an exercise workout, it is necessary to repeat the operating cycle so that in the course of an exercise session, the penis is subjected to a succession of ten or more operating cycles A to K, as shown in FIG. 3. Between successive operating cycles in which the organ goes from a flaccid to an erectile state and back, there is a relaxation interval R. The duration of interval R which may be several minutes, is adjusted by programmer 13 so as to be tailored to the existing condition of the subject being treated.
It must be borne in mind that no two subjects suffer from the same degree of male impotence. No two subjects possess tissues exhibiting the same ability to recover their plasticity. Hence with each subject, one must observe his penis and the level of negative pressure necessary to produce an erectile state, using no more pressure than is necessary for this purpose. And one must empirically determine the tolerance of the subject to repeated operating cycles. Thus the number of operating cycles which make up an exercise session and relaxation interval between these operating cycles must be adjusted to accommodate the subject being treated.
It is usually desirable that the subject only go through at least one exercise workout session a day, with no more than five workouts a week. As to the time it takes for a subject being exercised to regain the potency of his organ, this depends on his physical condition and the amount of exercise necessary to restore the tone of his tissues. Hence in some instances, there is a marked improvement in tone in a matter of weeks, while in other cases it may take several months.
The clinical pattern of recovery involves a gradual, but steady increase in erectile function. We have treated over 400 patients with this technique and none have failed to show a positive response. While the VED exercise technique acts to restore potency, once it is restored and the subject can function sexually this does preclude further treatment. As with athletes, the way to maintain muscle tone is to continue to exercise, just as a concert pianist must practice daily to maintain his digital dexterity. And while a recovered subject need not exercise his penile tissues five days a week, as he did when striving to recover his potency, he should continue to exercise at least once a week.
In the operating cycle shown in FIGS. 1 and 2, the negative pressure is such as to cause the male organ P to go from a flaccid to a fully erectile state and then back to a flaccid state; this being repeated with each new operating cycle. But it may be desirable to progressively increase the degree of exertion so as not to overtax the tissues being exercised. Thus, as shown in FIG. 3, the first operating cycle C1 may be arranged to cause the male organ to change from a flaccid state and to a sub-erectile state. This being about one half the level of the normal erectile state; the second cycle C2 raises the level somewhat higher, and the third cycle C3 raises it still higher, but below the full erectile state which is not attained until cycle C4.
This progressive pattern of operating cycles is then repeated in a subsequent series of cycles. Programmer 13 is provided with a keyboard 14 so that the operator of the apparatus can enter into the device timing parameters appropriate to the subject being treated.
While a technique in accordance with the invention serves to overcome male impotence, the said technique is useful in forestalling such impotence. Thus many men only occasionally experience difficulty in having an erection and are by no means impotent. Yet these men can benefit from the penile exercise technique, for an occasional penile exercise workout acts to maintain the fitness of the organ.
The technique is also beneficial in the treatment of female impotence when due to the loss of plasticity of the tissues of the clitoris whose tissues are similar to those of the male organ. But in order to exercise the tissues of the clitoris, the vacuum chamber for this purpose must be adapted to accommodate the clitoris such that when a negative pressure is produced, this draws blood into the clitoris which then becomes engorged.
While there has been disclosed a technique in accordance with the invention for restoring plasticity to tissues of a sexual organ, it will be appreciated that many changes may be made therein without departing from the spirit of the invention.

Claims (12)

We claim:
1. A technique for overcoming impotence due to a loss of plasticity of the tissues forming the sexual organ; said technique comprising the steps of:
A. subjecting the organ to be treated to an operating cycle in the course of which the organ is changed from a flaccid to an erectile state and then back to a flaccid state to cause the tissues to expand and contract; and
B. repeating the operating cycle a predetermined number of times to complete an exercise session that constitutes a workout of the organ and enhances the plasticity of the tissues.
2. A technique as set forth in claim 1, in which the sexual organ is a penis.
3. A technique as set forth in claim 1, in which the sexual organ is a clitoris.
4. A technique as set forth in claim 1, in which the operating cycle is produced by a vacuum erectile device having a vacuum chamber in which the organ is received, the vacuum during operating cycle producing a negative pressure causing blood to be drawn into the organ to render it erect.
5. A technique as set forth in claim 4, in which the vacuum erectile device includes a battery-operated pump associated with the vacuum chamber to expel air therefrom.
6. A technique as set forth in claim 5, in which the chamber is transparent so that the organ can be observed and its condition determined.
7. A technique as set forth in claim 5, in which the vacuum erectile device is programmed so that in the course of an exercise session, it undergoes a predetermined number of operating cycles.
8. A technique as set forth in claim 1, in which the exercise sessions are repeated over an extended period of time sufficient to cause the organ to go from a condition in which it is flabby to a condition in which it is rubbery.
9. A vacuum erectile device for treating a sexual organ that is impotent due to a loss of plasticity of the tissues forming the organ said device comprising:
A. a vacuum chamber in which the organ to be treated is received;
B. an electrically-powered vacuum pump coupled to the chamber for drawing air therefrom to produce a negative pressure drawing blood into the organ to cause it to assume an erectile state; and
C. control means coupled to the electrically-powered vacuum pump to cause it to undergo an operating cycle in the course of which the organ is changed from a flaccid to an erectile state and then back to a flaccid state, causing the tissues to expand and contract.
10. A device as set forth in claim 9, in which said control means is programmed acts to repeat the operating cycle a predetermined number of times during an exercise session that constitutes an exercise workout of the organ that enhance the plasticity of the tissues.
11. A device as set forth in claim 9, further including an indicator coupled thereto to indicate the prevailing level of negative pressure in the chamber.
12. A device as set forth in claim 10, in which the chamber is formed of transparent synthetic plastic material.
US09/299,284 1989-02-06 1999-04-26 Technique for restoring plasticity to tissues of a male or female organ Expired - Lifetime US6183414B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/299,284 US6183414B1 (en) 1999-04-26 1999-04-26 Technique for restoring plasticity to tissues of a male or female organ
US10/174,482 US20030023140A1 (en) 1989-02-06 2002-06-18 Pathlength corrected oximeter and the like

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/299,284 US6183414B1 (en) 1999-04-26 1999-04-26 Technique for restoring plasticity to tissues of a male or female organ

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US08/731,443 Continuation US6134460A (en) 1988-11-02 1996-10-15 Spectrophotometers with catheters for measuring internal tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/174,482 Continuation US20030023140A1 (en) 1989-02-06 2002-06-18 Pathlength corrected oximeter and the like

Publications (1)

Publication Number Publication Date
US6183414B1 true US6183414B1 (en) 2001-02-06

Family

ID=23154125

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/299,284 Expired - Lifetime US6183414B1 (en) 1989-02-06 1999-04-26 Technique for restoring plasticity to tissues of a male or female organ
US10/174,482 Abandoned US20030023140A1 (en) 1989-02-06 2002-06-18 Pathlength corrected oximeter and the like

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/174,482 Abandoned US20030023140A1 (en) 1989-02-06 2002-06-18 Pathlength corrected oximeter and the like

Country Status (1)

Country Link
US (2) US6183414B1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077970A1 (en) * 2002-10-16 2004-04-22 Julian Osbon Method, system and kit for treatment of peyronie's disease
US20050119521A1 (en) * 2003-12-02 2005-06-02 Pitcher Rex L. Vacuum exercise device for promoting expansion of soft-tissue
US7037257B1 (en) * 2002-08-22 2006-05-02 Koenig J Frank Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications
US20060235266A1 (en) * 2005-04-19 2006-10-19 Nanma Manufacturing Co. Ltd. Collapsible vacuum device
US20070129600A1 (en) * 2002-10-16 2007-06-07 Augusta Medical Sytems, Inc. Kit, system and method to treat erectile dysfunction
US20070156014A1 (en) * 2005-12-29 2007-07-05 Nikos Zafirakis Angled male member enlargement pump
US20080221426A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Methods and apparatus for detecting misapplied optical sensors
US20100041943A1 (en) * 2008-05-15 2010-02-18 Alagin Research LLC System and method for treating and/or preventing erection problems
US20100130813A1 (en) * 2008-11-24 2010-05-27 Dmitri Dozortsev Method and apparatus for attaining lucid dream state
US8287474B1 (en) 2002-08-22 2012-10-16 Koenig J Frank Method and apparatus for noninvasively increasing whole body blood flow and noninvasive physical exercise of limbs from the outside and from within the limb to treat diseases throughout the body
US8579837B1 (en) 2012-11-21 2013-11-12 ExploraMed NC6, LLC Devices and methods for promoting female sexual wellness
WO2014085736A1 (en) * 2012-11-30 2014-06-05 ExploraMed NC6, LLC Devices and methods for promoting female sexual wellness
US8862194B2 (en) 2008-06-30 2014-10-14 Covidien Lp Method for improved oxygen saturation estimation in the presence of noise
US20170224522A1 (en) * 2016-02-05 2017-08-10 Global Health & Innovation Vacuum therapy apparatus
US20170231864A1 (en) * 2016-02-11 2017-08-17 Kevin Joseph Dorsey Vacuum-driven personal device
US20180021212A1 (en) * 2015-02-17 2018-01-25 Tenga Co., Ltd. Decompression device for ejaculation promotion device
US11154414B2 (en) * 2018-05-15 2021-10-26 Nugyn, Inc. Apparatus and methods for treating venous occlusive disorders
US11179267B2 (en) * 2018-05-15 2021-11-23 Nugyn, Inc. Apparatus and methods for treating venous occlusive disorders
US20220401249A1 (en) * 2020-12-18 2022-12-22 Shanghai Realov Electronic Technology Co.?Ltd. Water And Gas Dual-Purpose Electric Erection Aid

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758503B2 (en) * 1997-01-27 2010-07-20 Lynn Lawrence A Microprocessor system for the analysis of physiologic and financial datasets
US6018673A (en) 1996-10-10 2000-01-25 Nellcor Puritan Bennett Incorporated Motion compatible sensor for non-invasive optical blood analysis
US20060161071A1 (en) 1997-01-27 2006-07-20 Lynn Lawrence A Time series objectification system and method
US8932227B2 (en) * 2000-07-28 2015-01-13 Lawrence A. Lynn System and method for CO2 and oximetry integration
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US9521971B2 (en) 1997-07-14 2016-12-20 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US20070191697A1 (en) 2006-02-10 2007-08-16 Lynn Lawrence A System and method for SPO2 instability detection and quantification
US6675031B1 (en) * 1999-04-14 2004-01-06 Mallinckrodt Inc. Method and circuit for indicating quality and accuracy of physiological measurements
US20090281838A1 (en) 2008-05-07 2009-11-12 Lawrence A. Lynn Medical failure pattern search engine
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US20060195041A1 (en) * 2002-05-17 2006-08-31 Lynn Lawrence A Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
US20070093721A1 (en) * 2001-05-17 2007-04-26 Lynn Lawrence A Microprocessor system for the analysis of physiologic and financial datasets
US6754516B2 (en) 2001-07-19 2004-06-22 Nellcor Puritan Bennett Incorporated Nuisance alarm reductions in a physiological monitor
US20080200775A1 (en) * 2007-02-20 2008-08-21 Lynn Lawrence A Maneuver-based plethysmographic pulse variation detection system and method
US7698909B2 (en) * 2002-10-01 2010-04-20 Nellcor Puritan Bennett Llc Headband with tension indicator
US7289837B2 (en) * 2002-10-01 2007-10-30 Nellcor Puritan Bennett Incorpoated Forehead sensor placement
US7006856B2 (en) * 2003-01-10 2006-02-28 Nellcor Puritan Bennett Incorporated Signal quality metrics design for qualifying data for a physiological monitor
US7016715B2 (en) 2003-01-13 2006-03-21 Nellcorpuritan Bennett Incorporated Selection of preset filter parameters based on signal quality
US7047056B2 (en) * 2003-06-25 2006-05-16 Nellcor Puritan Bennett Incorporated Hat-based oximeter sensor
US8412297B2 (en) 2003-10-01 2013-04-02 Covidien Lp Forehead sensor placement
US7120479B2 (en) 2004-02-25 2006-10-10 Nellcor Puritan Bennett Inc. Switch-mode oximeter LED drive with a single inductor
US7190985B2 (en) * 2004-02-25 2007-03-13 Nellcor Puritan Bennett Inc. Oximeter ambient light cancellation
US8611977B2 (en) * 2004-03-08 2013-12-17 Covidien Lp Method and apparatus for optical detection of mixed venous and arterial blood pulsation in tissue
US7534212B2 (en) 2004-03-08 2009-05-19 Nellcor Puritan Bennett Llc Pulse oximeter with alternate heart-rate determination
US7194293B2 (en) * 2004-03-08 2007-03-20 Nellcor Puritan Bennett Incorporated Selection of ensemble averaging weights for a pulse oximeter based on signal quality metrics
US7277741B2 (en) * 2004-03-09 2007-10-02 Nellcor Puritan Bennett Incorporated Pulse oximetry motion artifact rejection using near infrared absorption by water
US7392075B2 (en) 2005-03-03 2008-06-24 Nellcor Puritan Bennett Incorporated Method for enhancing pulse oximetry calculations in the presence of correlated artifacts
US7725146B2 (en) 2005-09-29 2010-05-25 Nellcor Puritan Bennett Llc System and method for pre-processing waveforms
US7725147B2 (en) * 2005-09-29 2010-05-25 Nellcor Puritan Bennett Llc System and method for removing artifacts from waveforms
US20070106126A1 (en) 2005-09-30 2007-05-10 Mannheimer Paul D Patient monitoring alarm escalation system and method
US20070100220A1 (en) * 2005-10-28 2007-05-03 Baker Clark R Jr Adjusting parameters used in pulse oximetry analysis
US7668579B2 (en) * 2006-02-10 2010-02-23 Lynn Lawrence A System and method for the detection of physiologic response to stimulation
US8702606B2 (en) * 2006-03-21 2014-04-22 Covidien Lp Patient monitoring help video system and method
US8380271B2 (en) 2006-06-15 2013-02-19 Covidien Lp System and method for generating customizable audible beep tones and alarms
US8064975B2 (en) 2006-09-20 2011-11-22 Nellcor Puritan Bennett Llc System and method for probability based determination of estimated oxygen saturation
US20080076977A1 (en) * 2006-09-26 2008-03-27 Nellcor Puritan Bennett Inc. Patient monitoring device snapshot feature system and method
US8696593B2 (en) 2006-09-27 2014-04-15 Covidien Lp Method and system for monitoring intracranial pressure
US7922665B2 (en) 2006-09-28 2011-04-12 Nellcor Puritan Bennett Llc System and method for pulse rate calculation using a scheme for alternate weighting
US7698002B2 (en) * 2006-09-29 2010-04-13 Nellcor Puritan Bennett Llc Systems and methods for user interface and identification in a medical device
US8175667B2 (en) 2006-09-29 2012-05-08 Nellcor Puritan Bennett Llc Symmetric LED array for pulse oximetry
US7925511B2 (en) * 2006-09-29 2011-04-12 Nellcor Puritan Bennett Llc System and method for secure voice identification in a medical device
US7848891B2 (en) 2006-09-29 2010-12-07 Nellcor Puritan Bennett Llc Modulation ratio determination with accommodation of uncertainty
US20080082338A1 (en) * 2006-09-29 2008-04-03 O'neil Michael P Systems and methods for secure voice identification and medical device interface
US8068891B2 (en) 2006-09-29 2011-11-29 Nellcor Puritan Bennett Llc Symmetric LED array for pulse oximetry
US8728059B2 (en) * 2006-09-29 2014-05-20 Covidien Lp System and method for assuring validity of monitoring parameter in combination with a therapeutic device
US20080081956A1 (en) * 2006-09-29 2008-04-03 Jayesh Shah System and method for integrating voice with a medical device
US20080097175A1 (en) * 2006-09-29 2008-04-24 Boyce Robin S System and method for display control of patient monitor
US8160668B2 (en) * 2006-09-29 2012-04-17 Nellcor Puritan Bennett Llc Pathological condition detector using kernel methods and oximeters
US7706896B2 (en) * 2006-09-29 2010-04-27 Nellcor Puritan Bennett Llc User interface and identification in a medical device system and method
US8068890B2 (en) * 2006-09-29 2011-11-29 Nellcor Puritan Bennett Llc Pulse oximetry sensor switchover
US20080200819A1 (en) * 2007-02-20 2008-08-21 Lynn Lawrence A Orthostasis detection system and method
US8265724B2 (en) * 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
JP4569615B2 (en) * 2007-09-25 2010-10-27 ブラザー工業株式会社 Printing device
US8204567B2 (en) * 2007-12-13 2012-06-19 Nellcor Puritan Bennett Llc Signal demodulation
US20090171167A1 (en) * 2007-12-27 2009-07-02 Nellcor Puritan Bennett Llc System And Method For Monitor Alarm Management
US8092993B2 (en) 2007-12-31 2012-01-10 Nellcor Puritan Bennett Llc Hydrogel thin film for use as a biosensor
US20090171173A1 (en) * 2007-12-31 2009-07-02 Nellcor Puritan Bennett Llc System and method for reducing motion artifacts in a sensor
US20090171174A1 (en) * 2007-12-31 2009-07-02 Nellcor Puritan Bennett Llc System and method for maintaining battery life
US20090171166A1 (en) * 2007-12-31 2009-07-02 Nellcor Puritan Bennett Llc Oximeter with location awareness
US20090171226A1 (en) * 2007-12-31 2009-07-02 Nellcor Puritan Bennett Llc System and method for evaluating variation in the timing of physiological events
US8750953B2 (en) 2008-02-19 2014-06-10 Covidien Lp Methods and systems for alerting practitioners to physiological conditions
US8275553B2 (en) 2008-02-19 2012-09-25 Nellcor Puritan Bennett Llc System and method for evaluating physiological parameter data
WO2009120600A2 (en) 2008-03-25 2009-10-01 The Curators Of The University Of Missouri Method and system for non-invasive blood glucose detection utilizing spectral data of one or more components other than glucose
US20090247851A1 (en) * 2008-03-26 2009-10-01 Nellcor Puritan Bennett Llc Graphical User Interface For Monitor Alarm Management
US8140272B2 (en) * 2008-03-27 2012-03-20 Nellcor Puritan Bennett Llc System and method for unmixing spectroscopic observations with nonnegative matrix factorization
US20090247854A1 (en) * 2008-03-27 2009-10-01 Nellcor Puritan Bennett Llc Retractable Sensor Cable For A Pulse Oximeter
US20090247850A1 (en) * 2008-03-28 2009-10-01 Nellcor Puritan Bennett Llc Manually Powered Oximeter
US8437822B2 (en) * 2008-03-28 2013-05-07 Covidien Lp System and method for estimating blood analyte concentration
US8364224B2 (en) * 2008-03-31 2013-01-29 Covidien Lp System and method for facilitating sensor and monitor communication
US8292809B2 (en) 2008-03-31 2012-10-23 Nellcor Puritan Bennett Llc Detecting chemical components from spectroscopic observations
US8112375B2 (en) * 2008-03-31 2012-02-07 Nellcor Puritan Bennett Llc Wavelength selection and outlier detection in reduced rank linear models
CN102961146B (en) * 2008-05-22 2015-09-23 密苏里大学董事会 The method and system of noninvasive Optical blood glucose detection is carried out with spectral data analysis
US9895068B2 (en) * 2008-06-30 2018-02-20 Covidien Lp Pulse oximeter with wait-time indication
US20090327515A1 (en) * 2008-06-30 2009-12-31 Thomas Price Medical Monitor With Network Connectivity
USD626561S1 (en) 2008-06-30 2010-11-02 Nellcor Puritan Bennett Llc Circular satseconds indicator and triangular saturation pattern detection indicator for a patient monitor display panel
USD626562S1 (en) 2008-06-30 2010-11-02 Nellcor Puritan Bennett Llc Triangular saturation pattern detection indicator for a patient monitor display panel
US8364220B2 (en) 2008-09-25 2013-01-29 Covidien Lp Medical sensor and technique for using the same
US20100076319A1 (en) * 2008-09-25 2010-03-25 Nellcor Puritan Bennett Llc Pathlength-Corrected Medical Spectroscopy
US8257274B2 (en) * 2008-09-25 2012-09-04 Nellcor Puritan Bennett Llc Medical sensor and technique for using the same
US8386000B2 (en) * 2008-09-30 2013-02-26 Covidien Lp System and method for photon density wave pulse oximetry and pulse hemometry
US8433382B2 (en) * 2008-09-30 2013-04-30 Covidien Lp Transmission mode photon density wave system and method
US8968193B2 (en) * 2008-09-30 2015-03-03 Covidien Lp System and method for enabling a research mode on physiological monitors
US8417309B2 (en) 2008-09-30 2013-04-09 Covidien Lp Medical sensor
WO2010051487A2 (en) * 2008-10-31 2010-05-06 Nellcor Puritan Bennett Llc System and method for facilitating observation of monitored physiologic data
CA2741026C (en) * 2008-10-31 2015-04-14 Nellcor Puritan Bennett Llc System and method for facilitating observation of monitored physiologic data
US20090171172A1 (en) * 2008-12-19 2009-07-02 Nellcor Puritan Bennett Llc Method and system for pulse gating
US20100240972A1 (en) * 2009-03-20 2010-09-23 Nellcor Puritan Bennett Llc Slider Spot Check Pulse Oximeter
US8515515B2 (en) 2009-03-25 2013-08-20 Covidien Lp Medical sensor with compressible light barrier and technique for using the same
US8221319B2 (en) 2009-03-25 2012-07-17 Nellcor Puritan Bennett Llc Medical device for assessing intravascular blood volume and technique for using the same
US8781548B2 (en) 2009-03-31 2014-07-15 Covidien Lp Medical sensor with flexible components and technique for using the same
US8509869B2 (en) 2009-05-15 2013-08-13 Covidien Lp Method and apparatus for detecting and analyzing variations in a physiologic parameter
US8494786B2 (en) 2009-07-30 2013-07-23 Covidien Lp Exponential sampling of red and infrared signals
US20110029865A1 (en) * 2009-07-31 2011-02-03 Nellcor Puritan Bennett Llc Control Interface For A Medical Monitor
US8494606B2 (en) 2009-08-19 2013-07-23 Covidien Lp Photoplethysmography with controlled application of sensor pressure
US8494604B2 (en) * 2009-09-21 2013-07-23 Covidien Lp Wavelength-division multiplexing in a multi-wavelength photon density wave system
US8788001B2 (en) * 2009-09-21 2014-07-22 Covidien Lp Time-division multiplexing in a multi-wavelength photon density wave system
US8704666B2 (en) * 2009-09-21 2014-04-22 Covidien Lp Medical device interface customization systems and methods
US8571621B2 (en) 2009-09-24 2013-10-29 Covidien Lp Minimax filtering for pulse oximetry
US8923945B2 (en) * 2009-09-24 2014-12-30 Covidien Lp Determination of a physiological parameter
US8798704B2 (en) * 2009-09-24 2014-08-05 Covidien Lp Photoacoustic spectroscopy method and system to discern sepsis from shock
EP2480997A2 (en) * 2009-09-24 2012-08-01 Nellcor Puritan Bennett LLC Determination of a physiological parameter
US9554739B2 (en) 2009-09-29 2017-01-31 Covidien Lp Smart cable for coupling a medical sensor to an electronic patient monitor
US8376955B2 (en) * 2009-09-29 2013-02-19 Covidien Lp Spectroscopic method and system for assessing tissue temperature
US8515511B2 (en) 2009-09-29 2013-08-20 Covidien Lp Sensor with an optical coupling material to improve plethysmographic measurements and method of using the same
US20110074342A1 (en) * 2009-09-30 2011-03-31 Nellcor Puritan Bennett Llc Wireless electricity for electronic devices
US8401608B2 (en) * 2009-09-30 2013-03-19 Covidien Lp Method of analyzing photon density waves in a medical monitor
US20110077470A1 (en) * 2009-09-30 2011-03-31 Nellcor Puritan Bennett Llc Patient Monitor Symmetry Control
JP5663900B2 (en) 2010-03-05 2015-02-04 セイコーエプソン株式会社 Spectroscopic sensor device and electronic device
US8391943B2 (en) 2010-03-31 2013-03-05 Covidien Lp Multi-wavelength photon density wave system using an optical switch
US8498683B2 (en) 2010-04-30 2013-07-30 Covidien LLP Method for respiration rate and blood pressure alarm management
US8930145B2 (en) 2010-07-28 2015-01-06 Covidien Lp Light focusing continuous wave photoacoustic spectroscopy and its applications to patient monitoring
US9380982B2 (en) 2010-07-28 2016-07-05 Covidien Lp Adaptive alarm system and method
US8610769B2 (en) 2011-02-28 2013-12-17 Covidien Lp Medical monitor data collection system and method
US9833146B2 (en) 2012-04-17 2017-12-05 Covidien Lp Surgical system and method of use of the same
CN104068865B (en) * 2014-04-24 2017-05-31 辛勤 A kind of method and portable set for measuring blood oxygen saturation
CN105286883A (en) * 2015-09-11 2016-02-03 蚌埠医学院 Pulse hemoglobin concentration non-invasive measurement method and device

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1225341A (en) * 1913-11-29 1917-05-08 Otto Lederer Surgical device.
US4378008A (en) * 1981-05-15 1983-03-29 Osbon Sr Geddings D Erection aid device
US4856498A (en) * 1987-03-30 1989-08-15 Osbon Medical Systems, Ltd. Vacuum generating and constriction apparatus for augmenting male potency
US5083556A (en) * 1990-05-31 1992-01-28 Osbon Medical Systems, Ltd. Penile cincture band operational apparatus
US5094230A (en) * 1991-09-19 1992-03-10 Clark Jr Buford E Method and apparatus for treating Peyronie's disease
US5195943A (en) * 1991-09-30 1993-03-23 Chaney John L Male organ restrictor ring applicator
US5421808A (en) * 1993-07-30 1995-06-06 Osbon Medical Systems, Ltd. Battery-operated male organ conditioning appliance
US5951460A (en) * 1996-01-11 1999-09-14 Vollrath; Andrew J. Non-invasive penile erection device

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1225341A (en) * 1913-11-29 1917-05-08 Otto Lederer Surgical device.
US4378008A (en) * 1981-05-15 1983-03-29 Osbon Sr Geddings D Erection aid device
US4856498A (en) * 1987-03-30 1989-08-15 Osbon Medical Systems, Ltd. Vacuum generating and constriction apparatus for augmenting male potency
US5083556A (en) * 1990-05-31 1992-01-28 Osbon Medical Systems, Ltd. Penile cincture band operational apparatus
US5094230A (en) * 1991-09-19 1992-03-10 Clark Jr Buford E Method and apparatus for treating Peyronie's disease
US5195943A (en) * 1991-09-30 1993-03-23 Chaney John L Male organ restrictor ring applicator
US5421808A (en) * 1993-07-30 1995-06-06 Osbon Medical Systems, Ltd. Battery-operated male organ conditioning appliance
US5951460A (en) * 1996-01-11 1999-09-14 Vollrath; Andrew J. Non-invasive penile erection device

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070260110A1 (en) * 2002-08-22 2007-11-08 Koenig J F Noninvasive angioplasty using momentary vacuum therapy
US7513879B2 (en) 2002-08-22 2009-04-07 Koenig J Frank Noninvasive angioplasty using momentary vacuum therapy
US7037257B1 (en) * 2002-08-22 2006-05-02 Koenig J Frank Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications
US8287474B1 (en) 2002-08-22 2012-10-16 Koenig J Frank Method and apparatus for noninvasively increasing whole body blood flow and noninvasive physical exercise of limbs from the outside and from within the limb to treat diseases throughout the body
US7037256B2 (en) * 2002-10-16 2006-05-02 Soma Blue, Inc. Method, system and kit for treatment of Peyronie's disease
US7186213B2 (en) 2002-10-16 2007-03-06 Augusta Medical Systems, Llc Method, system, and kit for treatment of a patient's extremity
US20070129600A1 (en) * 2002-10-16 2007-06-07 Augusta Medical Sytems, Inc. Kit, system and method to treat erectile dysfunction
US20040077970A1 (en) * 2002-10-16 2004-04-22 Julian Osbon Method, system and kit for treatment of peyronie's disease
US20060183969A1 (en) * 2002-10-16 2006-08-17 Augusta Medical Systems, Llc Method, system, and kit for treatment of a patient's extremity
US8137262B2 (en) 2002-10-16 2012-03-20 Augusta Medical Systems, Inc. Kit, system and method to treat erectile dysfunction
US20050119521A1 (en) * 2003-12-02 2005-06-02 Pitcher Rex L. Vacuum exercise device for promoting expansion of soft-tissue
US20060235266A1 (en) * 2005-04-19 2006-10-19 Nanma Manufacturing Co. Ltd. Collapsible vacuum device
US7572220B2 (en) 2005-04-19 2009-08-11 Nanma Manufacturing Co., Ltd. Collapsible vacuum device
US20070156014A1 (en) * 2005-12-29 2007-07-05 Nikos Zafirakis Angled male member enlargement pump
US20080221426A1 (en) * 2007-03-09 2008-09-11 Nellcor Puritan Bennett Llc Methods and apparatus for detecting misapplied optical sensors
US20100041943A1 (en) * 2008-05-15 2010-02-18 Alagin Research LLC System and method for treating and/or preventing erection problems
US8500626B2 (en) * 2008-05-15 2013-08-06 Alagin Research LLC System and method for treating and/or preventing erection problems
US8862194B2 (en) 2008-06-30 2014-10-14 Covidien Lp Method for improved oxygen saturation estimation in the presence of noise
US20100130813A1 (en) * 2008-11-24 2010-05-27 Dmitri Dozortsev Method and apparatus for attaining lucid dream state
US8579837B1 (en) 2012-11-21 2013-11-12 ExploraMed NC6, LLC Devices and methods for promoting female sexual wellness
CN104470485A (en) * 2012-11-30 2015-03-25 医疗探索Nc6公司 Devices and methods for promoting female sexual wellness
GB2512765A (en) * 2012-11-30 2014-10-08 Nuelle Inc Devices and methods for promoting female sexual wellness
WO2014085736A1 (en) * 2012-11-30 2014-06-05 ExploraMed NC6, LLC Devices and methods for promoting female sexual wellness
GB2512765B (en) * 2012-11-30 2015-04-01 Nuelle Inc Devices and methods for promoting female sexual wellness
CN104470485B (en) * 2012-11-30 2016-11-23 妮薇尔公司 For promoting the apparatus and method of female sexual health
US20180021212A1 (en) * 2015-02-17 2018-01-25 Tenga Co., Ltd. Decompression device for ejaculation promotion device
US20170224522A1 (en) * 2016-02-05 2017-08-10 Global Health & Innovation Vacuum therapy apparatus
US20170231864A1 (en) * 2016-02-11 2017-08-17 Kevin Joseph Dorsey Vacuum-driven personal device
US10588817B2 (en) * 2016-02-11 2020-03-17 Kevin Joseph Dorsey Vacuum-driven personal device
US11154414B2 (en) * 2018-05-15 2021-10-26 Nugyn, Inc. Apparatus and methods for treating venous occlusive disorders
US11179267B2 (en) * 2018-05-15 2021-11-23 Nugyn, Inc. Apparatus and methods for treating venous occlusive disorders
US20220401249A1 (en) * 2020-12-18 2022-12-22 Shanghai Realov Electronic Technology Co.?Ltd. Water And Gas Dual-Purpose Electric Erection Aid
US11957613B2 (en) * 2020-12-18 2024-04-16 Shanghai Realov Electronic Technology Co., Ltd. Water and gas dual-purpose electric erection aid

Also Published As

Publication number Publication date
US20030023140A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
US6183414B1 (en) Technique for restoring plasticity to tissues of a male or female organ
Witherington Vacuum constriction device for management of erectile impotence
US5853362A (en) Glandular stimulator device and method
CA1276516C (en) Surgical appliance for stimulating an erection
US5439007A (en) Suspensory
JPH04501372A (en) Implantable device and method for increasing penile erection
US5695444A (en) Male organ constrictor device and method of using the device
US20110224482A1 (en) Intimate Inseminator
US6319194B1 (en) Penis erection stabilizer using two connected flexible latex rings
US7678042B2 (en) Devices and methods for promoting or enhancing male erectile function
Hakim et al. Vacuum erection associated impotence and Peyronie's disease
US20100234683A1 (en) Therapeutic-sexual appliance for men
WO2002062275A1 (en) Techique for restoring plasticity to tissues of a male or female organ
RU2137446C1 (en) Method and device for impotence treatment
KR100411383B1 (en) Training equipment for corpus spongiosum
US5997470A (en) Penile tube and constrictor ring removal guide system and method of use
US6926666B2 (en) Penile tension system, device, kit, and methods of using same
Dengrove The mechanotherapy of sexual disorders
Ballard Treatment of erectile dysfunction: can pelvic muscle exercises improve sexual function?
RU28625U1 (en) Chamber simulator (TC) Muranivsky V.L.
CN110200793A (en) A kind of male physiotherapy apparatus tool
CN206152207U (en) Sports equipment for limb rehabilitation exercises
RU2114583C1 (en) Method for raising coitus feeling intensity
KR19990014635A (en) Penis exercise equipment
Witherington Vacuum devices for the impotent

Legal Events

Date Code Title Description
AS Assignment

Owner name: EBERT, MICHAEL, NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WYSOR, MICHAEL S.;WYSOR, WANDA D.;REEL/FRAME:010569/0957

Effective date: 19990420

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12